Endocannabinoid System (ECS) – Page 3 – Medical Marijuana

Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity

Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol

Endocannabinoids and energy homeostasis- An update

Endocannabinoid signalling and the deteriorating brain

Endocannabinoid CB1 receptor-mediated rises in Ca2+ and depolarization-induced suppression of inhibition

Endocannabinoid binding to the cannabinoid receptors- what is known and what remains unknown

Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol

Clinical endocannabinoid deficiency (CECD) revisited- Can this concept explain the therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant condi

Clinical Endocannabinoid Deficiency (CECD)- Can this Concept Explain Therapeutic Benefits of Cannabis in Migraine, Fibromyalgia, Irritable Bowel Syndrome and other Treatment-Resistant Conditions

Care and Feeding of the Endocannabinoid System- A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System